Regulation & law · 02/12/2022Updated: 10/17/2026 · 1 min read

DEA Provides Notice on Application for Bulk Marihuana Manufacturing

Summary

The Drug Enforcement Administration (DEA) has received an application from Alm Management to manufacture marihuana in bulk for scientific and medical research purposes, and will evaluate it in accordance with its regulations

Original source language: Federal Register — Justice DepartmentOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

Related business signals

Regulation & law · 9/14/2026

Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.

Cambrex High Point, Inc. has submitted an application to the U.S. government to be registered as a bulk manufacturer of controlled substances, a key step in the production and distribution of certain medications. The company is seeking to manufacture basic classes of controlled substances, as outlined in the accompanying SUPPLEMENTARY INFORMATION.

Read summary →

Regulation & law · 9/1/2026

Technical Amendments to the Regulations Providing Whistleblower Protection for Federal Bureau of Investigation Employees

The Department of Justice has made technical amendments to its regulations on whistleblower protection for FBI employees to align with organizational changes resulting from the restructuring of the Justice Management Division. The updated rules aim to ensure consistency with the Department's organizational structure.

Read summary →

Regulation & law · 9/11/2026

Joseph John Stubbers III, D.O.; Decision and Order

A medical doctor, Joseph John Stubbers III, D.O., has made a decision and order regarding an unspecified matter. The details of the decision and order are not provided in the given metadata.

Read summary →

Regulation & law · 9/8/2026

AndersonBrecon, Inc DBA PCI Pharma Services Seeks Registration as Controlled Substance Importer

AndersonBrecon, Inc DBA PCI Pharma Services has submitted an application to the government to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Read summary →

Regulation & law · 9/8/2026

Doctor's Decision Upheld: Stephen Bossenberry, M.D., Ruling Stands

A medical professional's decision has been upheld, with a ruling remaining in effect, following a formal review process

Read summary →

Regulation & law · 9/8/2026

Fresenius Kabi USA, LLC Seeks Registration as Controlled Substance Importer

Fresenius Kabi USA, LLC has submitted an application to the U.S. government to be registered as an importer of controlled substances, including basic classes of medications. The company aims to import these controlled substances for distribution in the United States.

Read summary →